Skip to main content

News & Events

Meetings, Workshops & Trainings
Regional Health Information Exchanges as Critical National Infrastructure: Supporting Federal Agency Missions
September 25, 2024
Learn More
View All Events
Meetings, Workshops & Trainings
Assessing Treatment Effects in Observational Data with Missing Confounders: A Comparative Study of Practical Doubly-Robust and Traditional Missing Data Methods
September 10, 2024
Learn More
View All Events
Meetings, Workshops & Trainings
2025 ISPE Annual Meeting
August 22, 2025
Learn More
View All Events
FDA Safety Communications
FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications
Learn More
View All Alerts
FDA Advisory Committee Meetings
Joint Meeting of the Drug Safety and Risk Management Advisory Committee and Psychopharmacologic Drugs Advisory Committee Meeting
Learn More
View All Meetings

Latest Publications & Presentations

Integrating Human and Artificial Intelligence for Robust Postmarketing Safety Surveillance Systems: Reflections From the FDA Sentinel Innovation Center
Publication
07/20/2026

To describe considerations for integration of human and artificial intelligence for creating a postmarketing surveillance system capable of timely and reliably identifying causal effects of…

Real World Evidence for Post-Marketing Drug Safety Outcomes: FDA’s Sentinel System
Presentation
06/14/2026

This presentation provides an overview of the Sentinel System and describes a project in which FDA evaluated GLP-1 RA use and risk of intentional self-harm in the Sentinel Distributed Database…

View All

Recent Sentinel Activity

View All Recent Activity